Stocks · News reference
8-K filing — REPLIGEN CORP (RGEN)
Filed: 2026-07-28 AccNo: 0001193125-26-318853 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Jul 28, 2026, 11:13 AM
- Checked
- Jul 28, 2026, 11:13 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
JP Morgan Maintains Overweight on Repligen, Raises Price Target to $175
Read original at benzingaNasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today
A deepening chip rout drags the Nasdaq while Coca-Cola and Sherwin-Williams beats power the Dow; oil dives 5% on Iran diplomacy as the Fed meets.
Read original at benzinga12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $936.3 million. As per the press release, Q2 earnings came out yesterday.
Read original at benzinga